Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients

about

Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients

Item

http://www.wikidata.org/entity/Q58700208

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Serum-based microRNA signature ...... in colorectal cancer patients

@en

Serum-based microRNA signature ...... in colorectal cancer patients

@nl

type

Item

label

Serum-based microRNA signature ...... in colorectal cancer patients

@en

Serum-based microRNA signature ...... in colorectal cancer patients

@nl

prefLabel

Serum-based microRNA signature ...... in colorectal cancer patients

@en

Serum-based microRNA signature ...... in colorectal cancer patients

@nl

P1476

Serum-based microRNA signature ...... in colorectal cancer patients

@en

P2093

Dengbo Ji

http://www.w3.org/2001/XMLSchema#string

Hailong Chen

http://www.w3.org/2001/XMLSchema#string

Jin Gu

http://www.w3.org/2001/XMLSchema#string

Jinhong Xia

http://www.w3.org/2001/XMLSchema#string

Jinying Jia

http://www.w3.org/2001/XMLSchema#string

Meng Qiao

http://www.w3.org/2001/XMLSchema#string

Ming Li

http://www.w3.org/2001/XMLSchema#string

Qi Dong

http://www.w3.org/2001/XMLSchema#string

Xinxin Cui

http://www.w3.org/2001/XMLSchema#string

Yunfeng Yao

http://www.w3.org/2001/XMLSchema#string

P2860

Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma

Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development

Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.

MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer.

MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.

Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer

P304

189-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EBIOM.2018.08.042

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30166271

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

microRNA

chemotherapy

P932

6156709

http://www.w3.org/2001/XMLSchema#string